REDUPHARMA SL
Company details
- Active NIF/CIF: B65628133
-
Telephone: Not available
-
Date of last BORME entry: 10/04/2014
-
Sector: Manufacturing
-
Address: Calle Travessera de Dalt, 4, 08024 Barcelona, Barcelona, España See in map
-
Website: Not available
-
Featured products:
More information on REDUPHARMA SL
-
10/04/2014 | BORME act no.: 159026 | Register: BARCELONARevocaciones -
10/04/2014 | BORME act no.: 159026 | Register: BARCELONANombramientos
-
28/02/2012 | BORME act no.: 95315 | Register: BARCELONACambio de domicilio social
-
16/09/2011 | BORME act no.: 373324 | Register: BARCELONAConstitución
-
16/09/2011 | BORME act no.: 373324 | Register: BARCELONANombramientos
Other information
The CIF assigned to REDUPHARMA SL is B65628133, while its current business status is active. The company operates in the economic sector identified by the CNAE 1086 - Elaboración de preparados alimenticios homogeneizados y alimentos dietéticos. In addition, its activity corresponds to the SIC classification 5149 - Comestibles y productos relacionados.
The template of REDUPHARMA SL includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. REDUPHARMA SL is registered in the Mercantile Registry of Barcelona and accumulates a total of 3 registration charges. The most recent announcement in Borme was published on 10/04/2014, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for REDUPHARMA SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about REDUPHARMA SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about REDUPHARMA SL comes from official data sources and is automatically updated every day.
Do you want to know more about REDUPHARMA SL??
Find out more about this company by consulting these reports:
